5. Inflammatory bowel disease
In-silico analysis of inflammatory bowel disease (IBD) GWAS loci to novel connections.
... inherent disease heterogeneity [11, 12], which demands patient stratification based on risk factors and development of tailored medicine ...of inflammatory diseases witnessed a rapid advancement in the last ...
21
Dietary Polydextrose Prevents Inflammatory Bowel Disease in Trinitrobenzenesulfonic Acid Model of Rat Colitis
... I nflammatory bowel disease (IBD) is a chronic in- flammatory process that is presented in two main distinct types: ulcerative colitis and Crohn’s disease. The etiology has not yet been defined, but ...
7
Inflammatory bowel disease and cognitive behavioural therapy : a systematic review and meta-analysis
... in 5 23–25,29,30 studies – 1 29 study found only a posttreatment improvement, not significant at follow-up; in a subgroup 30 analyses of the previous study, CD patients not medicated with systemic steroids, ...
33
Identification of novel predictor classifiers for inflammatory bowel disease by gene expression profiling.
... In order to discover new biomarkers related to the degree of intestinal inflammation we used the software package Prophet to identify the subset of genes that best discriminated CD1 from CD2 and UC1 from UC2, i.e. a ...
9
Sparse Modeling Reveals miRNA Signatures for Diagnostics of Inflammatory Bowel Disease.
... Inflammatory bowel disease (IBD) is a complex, polygenic, chronic intestinal disorder of unknown etiology, comprising two major types: Crohn’s disease (CD) and ulcerative colitis ...of ...
20
Association of NOD2 and IL23R with inflammatory bowel disease in Puerto Rico.
... of inflammatory bowel disease (IBD) to an admixed population such as Puerto Rico has the potential to shed light on IBD genes identified in studies of European populations, find new genes ...
8
Inflammatory bowel disease in the elderly : a review of the literature
... 3 Para além do risco inerente à patofisiologia da doença em si, os fármacos utilizados no tratamento da DII, nomeadamente os imunomoduladores e os agentes biológicos, estão também associados a um aumento de risco de ...
43
A case of ulcerative colitis presenting as pyoderma gangrenosum and lung nodule
... Exact pathogenesis of pyoderma gangrenosum is un- known. It has been described both as a cutaneous disorder of uncertain etiology (5) and a cutaneous manifestation of systemic disorders. About half of the cases of ...
5
Limited evidence for parent-of-origin effects in inflammatory bowel disease associated loci.
... common disease- susceptibility variants (G809R, R702W, and L1007fs) were therefore tested for POO effects in the Dutch CD trios, and subsequently the L1007fs variant was tested in the German replication cohort ...
8
Effects of Environmental Contaminants in Inflammatory Bowel Disease
... in Inflammatory Bowel ...Crohn’s Disease and Ulcerative ...of Inflammatory Bowel Disease, cancer except for non- melanoma skin cancer and that had died were ...Crohn’s ...
45
A Narrative Review on Anti-Tumor Necrosis Factor α Therapies in Inflammatory Bowel Disease During Pregnancy: Immunoglobulin Placental Translocation and its Impact
... The human placental barrier consists of a layer of multi- nucleated cells, known as syncytiotrophoblast. The syn- cytiotrophoblast layer is already formed 4 to 5 days after conception, when the blastocyst is ...
8
J. Coloproctol. (Rio J.) vol.37 número4
... “Inflammatory Bowel Disease Questionnaire (IBDQ)”, a questionnaire translated and validated in Por- tuguese, was the instrument applied, along with a small form on morbidity and sociodemographic ...
6
Farnesoid X receptor (FXR) activation and FXR genetic variation in inflammatory bowel disease.
... Rian M. Nijmeijer 1. , Raffaella M. Gadaleta 2,3,4. , Saskia W. C. van Mil 3 , Adriaan A. van Bodegraven 5 , J. Bart A. Crusius 6 , Gerard Dijkstra 7 , Daan W. Hommes 8 , Dirk J. de Jong 9 , Pieter C. F. Stokkers ...
6
Cytomegalovirus infection in inflammatory bowel disease is not associated with worsening of intestinal inflammatory activity.
... The serologic status of CMV in the blood of patients is shown in Table 4. Only 24 patients were not infected with CMV, and 90,9% of patients exhibited IgG antibodies against CMV in the blood, indicating previous CMV ...
8
Classical and recent advances in the treatment of inflammatory bowel diseases
... of 5 mg/kg and variable dosing schedules ...the disease remission rates in patients who have anti-IFX antibodies are equal to the rates seen in those negative for anti-IFX ...
12
MycobacteriuM aviuM suBsP paratuberculosis and croHn’s disease
... Evidences exist that support an infectious etiology in CD: (i) a concordance rate of only 44% between monozygotic twins with inflammatory bowel disease (Tysk et al., 1988); (ii) clustering of IBD ...
7
Treatment of inflammatory bowel disease and pregnancy: a review of the literature
... inlammatory bowel disease is diagnosed frequently among woman of childbearing ...inlammatory bowel disease in ...inlammatory bowel disease in pregnant ...
5
J. Coloproctol. (Rio J.) vol.37 número1
... There is no consensus among different organizations and societies about surveillance strategies, which means that there are different recommendations. The applica- tion of surveillance strategies for all people with CD ...
8
Rev. Bras. Enferm. vol.70 número6
... The search was conducted between July and August 2016, and the terms used were the Health Sciences Descriptors (DeCS) in Portuguese and Spanish, respectively: pediatria/ pediatría; doença crônica; autocuidado ...
12
J. Pediatr. (Rio J.) vol.82 número6 en v82n6a01
... with inflammatory bowel disease and gastroesophageal reflux disease, suggesting that symptoms such as constipation and fecal incontinence, which do not usually lead to major illness and school ...
3